1. Home
  2. AMRX vs APGE Comparison

AMRX vs APGE Comparison

Compare AMRX & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$13.34

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$78.60

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
APGE
Founded
2002
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.7B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
AMRX
APGE
Price
$13.34
$78.60
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$13.25
$101.89
AVG Volume (30 Days)
1.7M
1.0M
Earning Date
10-30-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$2,934,959,000.00
N/A
Revenue This Year
$9.99
N/A
Revenue Next Year
$6.67
N/A
P/E Ratio
$807.28
N/A
Revenue Growth
9.50
N/A
52 Week Low
$6.69
$26.20
52 Week High
$13.25
$80.99

Technical Indicators

Market Signals
Indicator
AMRX
APGE
Relative Strength Index (RSI) 68.90 65.69
Support Level $12.33 $72.56
Resistance Level $12.99 $78.34
Average True Range (ATR) 0.30 3.38
MACD 0.00 -0.51
Stochastic Oscillator 92.28 74.20

Price Performance

Historical Comparison
AMRX
APGE

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: